does pfizer make a glp 1 ADA '26: Lilly's dominance, Pfizer's 'foundational' drug and Roche's 'me-too' option Pfizer Is Going All In

If CagriSema follows the same route, a UK private-pharmacy launch in late 2026 or 2027 is plausible, assuming Novo Nordisk submits an application to the MHRA in the coming months

Pharm Res 41 , 19912014 (2024)

It is also approved in the United States for the reduction of major adverse cardiovascular events such as death, heart attack, or stroke in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors

Section symposium, Honolulu, Hawaii, 13:032 Veljaca M, Sladoljev P, Mildner B (2003) Tolerability and pharmacokinetics of PL 14736, a novel agent for treatment of ulcerative colitis, in healthy male volunteers